Coronavirus vaccine gets positive results in first human trial New York Post Coronavirus vaccine in China produces neutralizing antibodies in early-stage trial CNBCSafety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial The LancetWhy we might not get a coronavirus vaccine The GuardianEarly Coronavirus Immunity Data Fuel Promise for a Vaccine Scientific AmericanView Full Coverage on Google News